Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands
Texas
77381-1160
United States
Tel: 281-863-3000
Fax: 281-863-8088
Website: http://www.lexpharma.com/
415 articles about Lexicon Pharmaceuticals, Inc.
-
Lexicon Pharmaceuticals, Inc. to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
4/22/2009
-
Lexicon Pharmaceuticals, Inc. Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
3/5/2009
-
Lexicon Pharmaceuticals, Inc. Reports 2008 Fourth Quarter and Full Year Financial Results
2/25/2009
-
Lexicon Pharmaceuticals, Inc. to Report Fourth Quarter and Year End 2008 Financial Results On February 25, 2009
2/18/2009
-
Lexicon Pharmaceuticals, Inc. to Cut 102 Jobs
1/23/2009
-
Lexicon Pharmaceuticals, Inc. Initiates Phase 2 Clinical Trial of LX1031 in Patients With Irritable Bowel Syndrome
1/12/2009
-
Lexicon Pharmaceuticals, Inc. to Present At the 27th Annual JPMorgan Healthcare Conference
1/9/2009
-
Lexicon Pharmaceuticals, Inc.'s Memory Drug Fails Mid-Stage Study
12/12/2008
-
Lexicon Pharmaceuticals, Inc. to Present At Two Upcoming Healthcare Conferences
11/25/2008
-
Lexicon Pharmaceuticals, Inc.'s Drug Candidate LX1032 for Carcinoid Syndrome Successfully Completes Phase 1 Clinical Trials
11/13/2008
-
Lexicon Pharmaceuticals, Inc. Reports 2008 Third Quarter Financial Results
10/30/2008
-
Lexicon Pharmaceuticals, Inc. Presents Phase 1 Clinical Trial Results for LX2931 At American College of Rheumatology Annual Meeting
10/27/2008
-
Lexicon Pharmaceuticals, Inc. to Report Third Quarter 2008 Financial Results On October 30, 2008
10/17/2008
-
Lexicon Pharmaceuticals, Inc. to Present Clinical Data for LX2931, an Investigational New Drug for Rheumatoid Arthritis
10/15/2008
-
Lexicon Pharmaceuticals, Inc.' Drug Candidate for Irritable Bowel Syndrome Completes Phase 1 Clinical Trial Showing Positive Results
7/29/2008
-
Lexicon Pharmaceuticals, Inc. Reports 2008 Second Quarter Financial Results
7/29/2008
-
Lexicon Pharmaceuticals, Inc. to Report Second Quarter 2008 Financial Results On July 29, 2008
7/18/2008
-
Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals, Inc.
6/10/2008
-
Lexicon Pharmaceuticals, Inc.'s Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
6/3/2008
-
Lexicon Pharmaceuticals, Inc. to Cut About 20% of Workforce; CFO to Leave
5/28/2008